• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Director Lavange Lisa was granted 1,771 shares, increasing direct ownership by 20% to 10,834 units (SEC Form 4)

    11/4/25 4:38:00 PM ET
    $SLP
    EDP Services
    Technology
    Get the next $SLP alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    LaVange Lisa

    (Last) (First) (Middle)
    800 PARK OFFICES DRIVE
    SUITE 401

    (Street)
    RESEARCH TRIANGLE PARK NC 27709

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Simulations Plus, Inc. [ SLP ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    11/03/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 11/03/2025 A 1,771 A $0(1) 10,834 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Stock granted as independent director compensation, issued under the issuer's 2021 Equity Incentive Plan.
    Remarks:
    /s/ William Frederick, attorney-in-fact for Lisa LaVange 11/04/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $SLP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SLP

    DatePrice TargetRatingAnalyst
    9/30/2025$16.00Hold
    TD Cowen
    7/15/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    11/15/2024$39.00Overweight
    Stephens
    7/29/2024$47.00Overweight
    KeyBanc Capital Markets
    7/16/2024Mkt Perform
    JMP Securities
    6/28/2024Outperform
    William Blair
    5/9/2023$55.00Buy
    BTIG Research
    10/26/2021$65.00 → $53.00Hold → Buy
    Craig Hallum
    More analyst ratings

    $SLP
    SEC Filings

    View All

    Simulations Plus Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits

    8-K - Simulations Plus, Inc. (0001023459) (Filer)

    12/8/25 4:09:06 PM ET
    $SLP
    EDP Services
    Technology

    SEC Form 10-K filed by Simulations Plus Inc.

    10-K - Simulations Plus, Inc. (0001023459) (Filer)

    12/1/25 4:16:05 PM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Simulations Plus, Inc. (0001023459) (Filer)

    12/1/25 4:06:44 PM ET
    $SLP
    EDP Services
    Technology

    $SLP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lavange Lisa sold $14,644 worth of shares (866 units at $16.91), decreasing direct ownership by 8% to 9,968 units (SEC Form 4)

    4 - Simulations Plus, Inc. (0001023459) (Issuer)

    12/2/25 4:14:15 PM ET
    $SLP
    EDP Services
    Technology

    Director Lavange Lisa was granted 1,771 shares, increasing direct ownership by 20% to 10,834 units (SEC Form 4)

    4 - Simulations Plus, Inc. (0001023459) (Issuer)

    11/4/25 4:38:00 PM ET
    $SLP
    EDP Services
    Technology

    Director Woltosz Walter S was granted 1,771 shares, increasing direct ownership by 0.05% to 3,288,002 units (SEC Form 4)

    4 - Simulations Plus, Inc. (0001023459) (Issuer)

    11/4/25 4:36:01 PM ET
    $SLP
    EDP Services
    Technology

    $SLP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Simulations Plus Positioned to Capitalize on FDA's Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions

    Validated engines and AI-orchestrated ecosystem align with the emerging regulatory framework Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today responded to the U.S. Food and Drug Administration's draft guidance on streamlined nonclinical safety studies for monospecific monoclonal antibodies. The guidance encourages reduced reliance on animal studies and elevates mechanistic understanding, pharmacokinetics, and integrated weight-of-evidence (WoE) assessments for nonclinical decision-making. "The FDA's draft guidance signals a clear regulatory mandate towa

    12/9/25 7:55:00 AM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results

    Reaffirms fiscal 2026 revenue guidance of $79 to $82 million and adjusted diluted EPS guidance of $1.03 to $1.10  Investor Day on January 21, 2026, to present new product vision and AI solutions Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in cheminformatics, biosimulation, clinical operations solutions and medical communications that accelerate biopharma innovation, today reported financial results for its fourth quarter and fiscal 2025, ended August 31, 2025. Fourth Quarter 2025 Financial Highlights (as compared to fourth quarter 2024) Total revenue decreased 6% to $17.5 million Software revenue decreased 9% to $9.0 million, representi

    12/1/25 4:05:00 PM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance

    Provides preliminary fiscal 2026 revenue guidance of $79 to $82 million and adjusted diluted EPS guidance of $1.03 to $1.10 Fourth quarter and fiscal year 2025 results to be reported December 1, 2025 Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced preliminary results for its fiscal year 2025 and issued preliminary guidance and management outlook for fiscal year 2026 as follows:     Fiscal 2025 Preliminary   Fiscal 2026 Guidance Revenue   $

    10/22/25 7:50:00 AM ET
    $SLP
    EDP Services
    Technology

    $SLP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen initiated coverage on Simulations Plus with a new price target

    TD Cowen initiated coverage of Simulations Plus with a rating of Hold and set a new price target of $16.00

    9/30/25 8:58:03 AM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Simulations Plus from Overweight to Sector Weight

    7/15/25 8:39:07 AM ET
    $SLP
    EDP Services
    Technology

    Stephens initiated coverage on Simulations Plus with a new price target

    Stephens initiated coverage of Simulations Plus with a rating of Overweight and set a new price target of $39.00

    11/15/24 8:20:56 AM ET
    $SLP
    EDP Services
    Technology

    $SLP
    Financials

    Live finance-specific insights

    View All

    Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results

    Reaffirms fiscal 2026 revenue guidance of $79 to $82 million and adjusted diluted EPS guidance of $1.03 to $1.10  Investor Day on January 21, 2026, to present new product vision and AI solutions Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in cheminformatics, biosimulation, clinical operations solutions and medical communications that accelerate biopharma innovation, today reported financial results for its fourth quarter and fiscal 2025, ended August 31, 2025. Fourth Quarter 2025 Financial Highlights (as compared to fourth quarter 2024) Total revenue decreased 6% to $17.5 million Software revenue decreased 9% to $9.0 million, representi

    12/1/25 4:05:00 PM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance

    Provides preliminary fiscal 2026 revenue guidance of $79 to $82 million and adjusted diluted EPS guidance of $1.03 to $1.10 Fourth quarter and fiscal year 2025 results to be reported December 1, 2025 Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced preliminary results for its fiscal year 2025 and issued preliminary guidance and management outlook for fiscal year 2026 as follows:     Fiscal 2025 Preliminary   Fiscal 2026 Guidance Revenue   $

    10/22/25 7:50:00 AM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Reports Third Quarter Fiscal 2025 Financial Results

    Updated full-year revenue guidance of between $76 to $80 million and adjusted diluted EPS of $0.93 to $1.06 Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its third quarter fiscal 2025, ended May 31, 2025. Third Quarter 2025 Financial Highlights (as compared to third quarter 2024) Total revenue increased 10% to $20.4 million Software revenue increased 6% to $12.6 million, representing 62% of total revenue Services revenue increased 17% to $7.7 millio

    7/14/25 4:05:00 PM ET
    $SLP
    EDP Services
    Technology

    $SLP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Simulations Plus Inc.

    SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

    8/8/24 2:18:03 PM ET
    $SLP
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Simulations Plus Inc. (Amendment)

    SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

    2/13/24 5:13:58 PM ET
    $SLP
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Simulations Plus Inc. (Amendment)

    SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

    2/12/24 4:59:04 PM ET
    $SLP
    EDP Services
    Technology

    $SLP
    Leadership Updates

    Live Leadership Updates

    View All

    AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space. Uber Technologies Inc. (NYSE:UBER) will replace Charter Communications Inc. (NASD: CHTR) in the S&P 100. Charter Communications will remain in the S&P 500.AppLovin Corp. (NASD: APP), Robinhood Markets Inc. (NASD: H

    9/5/25 6:34:00 PM ET
    $ACHC
    $APP
    $BGS
    Medical Specialities
    Health Care
    Computer Software: Programming Data Processing
    Technology

    QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus

    QHP Capital, L.P. ("QHP"), an investor in technology and services companies in the life sciences and healthcare sectors, today announced its sale of Pro-ficiency, LLC ("Pro-ficiency" or the "Company"), a leader in providing tech-enabled training and compliance solutions for clinical trial investigators and site staff, to Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy. Michael Raymer, Chief Executive Officer of Pro-ficiency, said, "We are excited to join the Simulations Plus team, which has a well-established and recognized leadership position in modeling and simulations wi

    6/12/24 8:58:00 AM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Names Industry Veteran Will Frederick as Chief Financial Officer

    LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), announced today the appointment of Will Frederick as chief financial officer (CFO), succeeding John Kneisel, who retires after seven years with the company. Will Frederick brings more than 25 years of financial leadership experience to the company. He has a proven track record of developing and implementing strategies to drive revenue growth, increase profitability, managing merger & acquisition activities and achieving corporate objectives. He has global experience with both publicly traded and privately held companies including Pharsight, Entelos, Avaya, The Walt Disney Company and Ford Motor Company, among

    12/1/20 4:05:00 PM ET
    $DIS
    $SLP
    $F
    Services-Misc. Amusement & Recreation
    Consumer Discretionary
    EDP Services
    Technology